Int J Med Sci 2024; 21(1):27-36. doi:10.7150/ijms.76817 This issue Cite

Review

Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases

Xi-Xi Cheng1,2, Ming-Qing Li3,4,5✉, Ting Peng1,2✉

1. Shanghai Changning Maternity & Infant Health Hospital, China.
2. The Department of Obstetrics, Shanghai Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200080, China.
3. NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, China.
4. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, China.
5. Laboratory for Reproductive Immunology, Institute of Obstetrics and Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, China.

Citation:
Cheng XX, Li MQ, Peng T. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases. Int J Med Sci 2024; 21(1):27-36. doi:10.7150/ijms.76817. https://www.medsci.org/v21p0027.htm
Other styles

File import instruction

Abstract

Graphic abstract

Prokineticin 1 (PROK1) is a secreted protein involved in a range of physiological activities such as cell proliferation, migration, angiogenesis, and neuronal cell proliferation. Emerging evidences show that PROK1/PROK receptors (PROKRs) are expressed by trophoblasts, and decidual stroma cells at the maternal-fetal interface. PROK1 plays a critical role in successful pregnancy establishment by regulating the decidualization, implantation and placental development. Dysregulation of prokineticin signaling has been described in certain pathological states associated with pregnancy, including pre-eclampsia, recurrent miscarriage and fetal growth restriction. In this review, the expression and pleiotropic roles of PROK1 under physiological and pathological pregnancy conditions are discussed.

Keywords: prokineticin1, maternal-fetal interface, angiogenesis, recurrent miscarriage, preeclampsia, fetal growth restriction


Citation styles

APA
Cheng, X.X., Li, M.Q., Peng, T. (2024). Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases. International Journal of Medical Sciences, 21(1), 27-36. https://doi.org/10.7150/ijms.76817.

ACS
Cheng, X.X.; Li, M.Q.; Peng, T. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases. Int. J. Med. Sci. 2024, 21 (1), 27-36. DOI: 10.7150/ijms.76817.

NLM
Cheng XX, Li MQ, Peng T. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases. Int J Med Sci 2024; 21(1):27-36. doi:10.7150/ijms.76817. https://www.medsci.org/v21p0027.htm

CSE
Cheng XX, Li MQ, Peng T. 2024. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases. Int J Med Sci. 21(1):27-36.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image